Bruker Announces Quarterly Dividend
Bruker (Nasdaq: BRKR) has announced a quarterly cash dividend of $0.05 per share on its common stock. The dividend is set to be paid on September 16, 2024, to stockholders of record as of September 2, 2024. This decision, approved by Bruker's Board of Directors, demonstrates the company's commitment to returning value to its shareholders through regular dividend payments.
Bruker (Nasdaq: BRKR) ha annunciato un dividendo in contante trimestrale di 0,05 $ per azione sulle sue azioni ordinarie. Il dividendo sarà pagato il 16 settembre 2024, agli azionisti registrati al 2 settembre 2024. Questa decisione, approvata dal Consiglio di Amministrazione di Bruker, dimostra l'impegno dell'azienda a restituire valore ai propri azionisti attraverso pagamenti di dividendi regolari.
Bruker (Nasdaq: BRKR) ha anunciado un dividendo en efectivo trimestral de $0.05 por acción sobre sus acciones comunes. El dividendo se pagará el 16 de septiembre de 2024 a los accionistas registrados a partir del 2 de septiembre de 2024. Esta decisión, aprobada por la Junta Directiva de Bruker, demuestra el compromiso de la empresa de devolver valor a sus accionistas a través de pagos regulares de dividendos.
Bruker (Nasdaq: BRKR)는 보통주에 대해 주당 0.05달러의 분기 현금 배당금을 발표했습니다. 배당금은 2024년 9월 16일에 지급될 예정이며, 2024년 9월 2일 기준으로 주주에게 지급됩니다. 이 결정은 Bruker의 이사회에서 승인되었으며, 정기적인 배당금을 통해 주주에게 가치를 환원하려는 회사의 의지를 보여줍니다.
Bruker (Nasdaq: BRKR) a annoncé un dividende en espèces trimestriel de 0,05 $ par action sur ses actions ordinaires. Le dividende sera versé le 16 septembre 2024 aux actionnaires enregistrés au 2 septembre 2024. Cette décision, approuvée par le conseil d'administration de Bruker, démontre l'engagement de l'entreprise à restituer de la valeur à ses actionnaires par le biais de paiements de dividendes réguliers.
Bruker (Nasdaq: BRKR) hat eine vierteljährliche Barausschüttung von 0,05 $ pro Aktie auf seine Stammaktien bekannt gegeben. Die Ausschüttung soll am 16. September 2024 an die Aktionäre, die am 2. September 2024 eingetragen sind, ausgezahlt werden. Diese Entscheidung, die vom Vorstand von Bruker genehmigt wurde, zeigt das Engagement des Unternehmens, den Aktionären durch regelmäßige Ausschüttungen Wert zurückzugeben.
- Consistent dividend payment indicates financial stability
- Dividend provides regular income for shareholders
- None.
About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR)
Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit www.bruker.com.
Forward-Looking Statements
Any statements contained in this press release which do not describe historical facts may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding expected quarterly cash dividends in 2024. Any forward-looking statements contained herein are based on current expectations, but are subject to risks and uncertainties that could cause actual results to differ materially from those indicated, including, but not limited to, those risk factors discussed from time to time in our filings with the Securities and Exchange Commission, or SEC. These and other factors are identified and described in more detail in our filings with the SEC, including, without limitation, our annual report on Form 10-K for the year ended December 31, 2023, as may be updated by our quarterly reports on Form 10-Q. We expressly disclaim any intent or obligation to update these forward-looking statements other than as required by law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240812821873/en/
Joe Kostka
Associate Director, Investor Relations
Bruker Corporation
T: +1 (978) 313-5800
E: Investor.Relations@bruker.com
Source: Bruker Corporation
FAQ
What is the amount of Bruker's (BRKR) quarterly dividend for September 2024?
When will Bruker (BRKR) pay its next quarterly dividend?
What is the record date for Bruker's (BRKR) September 2024 dividend?